Literature DB >> 12609544

De novo identification of tumor-specific internalizing human antibody-receptor pairs by phage-display methods.

Changshou Gao1, Shenlan Mao, Francesca Ronca, Sufei Zhuang, Vito Quaranta, Peter Wirsching, Kim D Janda.   

Abstract

Three tumor-specific, internalizing human single-chain Fvs (scFvs) were obtained by direct selection against tumor cells from a large, nonimmune scFv-phage library pre-subtracted with various normal human cells. After scFv selection and characterization for cell binding and internalization, the scFvs were also employed in immunoprecipitations to identify putative receptors. In the case of a prostate tumor-cell specific scFv PR5, the receptor that mediated endocytosis was shown to be the transferrin receptor. For two pancreatic adenocarcinoma specific scFvs SW1 and PAN10, the alpha(3)beta(1) integrin was identified. The scFv SW1 was studied in further detail and found to induce functional effects as a ligand-mimetic by mediating cell adhesion and migration. The results demonstrated the feasibility of utilizing enhanced phage-display methods as a rapid and general approach for not only direct isolation of human internalizing scFvs, but also for identifying tumor cell-surface receptors from various classes. The use of scFv constructs that target tumor cells and undergo internalization could have significant impact on the future of cancer and gene therapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12609544     DOI: 10.1016/s0022-1759(02)00522-7

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  12 in total

Review 1.  Selection and characterization of cell binding and internalizing phage antibodies.

Authors:  Yu Zhou; Lequn Zhao; James D Marks
Journal:  Arch Biochem Biophys       Date:  2012-05-22       Impact factor: 4.013

2.  Selection of scFvs specific for the HepG2 cell line using ribosome display.

Authors:  Lei Zhou; Wei-Ping Mao; Juan Fen; Hong-Yun Liu; Chuan-Jing Wei; Wen-Xiu Li; Feng-Yun Zhou
Journal:  J Biosci       Date:  2009-06       Impact factor: 1.826

Review 3.  Selection strategies for anticancer antibody discovery: searching off the beaten path.

Authors:  David Sánchez-Martín; Morten Dræby Sørensen; Simon Lykkemark; Laura Sanz; Peter Kristensen; Erkki Ruoslahti; Luis Álvarez-Vallina
Journal:  Trends Biotechnol       Date:  2015-03-26       Impact factor: 19.536

4.  Internalizing cancer antibodies from phage libraries selected on tumor cells and yeast-displayed tumor antigens.

Authors:  Yu Zhou; Hao Zou; Shaoyi Zhang; James D Marks
Journal:  J Mol Biol       Date:  2010-09-17       Impact factor: 5.469

5.  Combinatorial antibody libraries from cancer patients yield ligand-mimetic Arg-Gly-Asp-containing immunoglobulins that inhibit breast cancer metastasis.

Authors:  Brunhilde Felding-Habermann; Richard A Lerner; Antonietta Lillo; Shufei Zhuang; Martin R Weber; Sandra Arrues; Changshou Gao; Shenlan Mao; Alan Saven; Kim D Janda
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-24       Impact factor: 11.205

6.  Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies.

Authors:  Anne-Laure Goenaga; Yu Zhou; Christine Legay; Houcine Bougherara; Lan Huang; Bin Liu; Daryl C Drummond; Dmitri B Kirpotin; Christian Auclair; James D Marks; Marie-Alix Poul
Journal:  Mol Immunol       Date:  2007-05-10       Impact factor: 4.407

7.  Can phage display be used as a tool to functionally identify endogenous eat-me signals in phagocytosis?

Authors:  Nora B Caberoy; Yixiong Zhou; Wei Li
Journal:  J Biomol Screen       Date:  2009-06-16

Review 8.  Display technologies: application for the discovery of drug and gene delivery agents.

Authors:  Anna Sergeeva; Mikhail G Kolonin; Jeffrey J Molldrem; Renata Pasqualini; Wadih Arap
Journal:  Adv Drug Deliv Rev       Date:  2006-10-06       Impact factor: 15.470

9.  Killing cancer cells by targeted drug-carrying phage nanomedicines.

Authors:  Hagit Bar; Iftach Yacoby; Itai Benhar
Journal:  BMC Biotechnol       Date:  2008-04-03       Impact factor: 2.563

10.  State of the art in tumor antigen and biomarker discovery.

Authors:  Klervi Even-Desrumeaux; Daniel Baty; Patrick Chames
Journal:  Cancers (Basel)       Date:  2011-06-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.